H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in Abilene have diagnosed diabetes — about even with the U.S. 12% figure. Census population 125,182. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Abilene clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Abilene storefront.
Non-Surgical Joint Care Solutions in Abilene, TX for clinics & physicians. Non-surgical joint care with bi… Compliance support & pricing — contact Hawk Medical.
Abilene is a city under 250k (125,182 Census). CDC PLACES (2023, crude) estimates 11.9% of adults in Abilene have diagnosed diabetes — about even with the U.S. 12% figure. Adult arthritis here is 22.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Non-Surgical Joint Care Solutions notes (how the product actually works)JH reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Abilene is 11.9% or not. PLACES is planning data. The LCD is the claim.
If you already buy non surgical joint care elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 11.9% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 35.3%; arthritis is 22.7%. That is place-level BRFSS modeling, not a clinic census and not a Abilene trial.
Texas is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Texas.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Abilene tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Abilene, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Abilene is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Abilene — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Abilene. Useful for joint-program math; still needs a diagnosis and privileging.
No Abilene storefront. Joe Bradley is an active practice owner. non surgical joint care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.